Butamben
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11148 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 43 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | bronchitis | KG + DL |
| 2 | severe nonproliferative diabetic retinopathy | KG + DL |
| 3 | acrodermatitis chronica atrophicans | KG + DL |
| 4 | neonatal dermatomyositis | KG + DL |
| 5 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 6 | amyopathic dermatomyositis | KG + DL |
| 7 | acne keloid | KG + DL |
| 8 | cauda equina syndrome | KG + DL |
| 9 | hydroa vacciniforme, familial | KG + DL |
| 10 | diabetic retinopathy | KG + DL |
| 11 | dry eye syndrome | KG + DL |
| 12 | gastroduodenitis | KG + DL |
| 13 | peptic ulcer disease | KG + DL |
| 14 | adult-onset myasthenia gravis | KG + DL |
| 15 | neonatal myasthenia gravis | KG + DL |
| 16 | autoimmune disease of peripheral nervous system | KG + DL |
| 17 | myasthenia gravis with thymus hyperplasia | KG + DL |
| 18 | disease of receptor activity | KG + DL |
| 19 | pityriasis simplex | KG + DL |
| 20 | exanthem (disease) | KG + DL |
| 21 | diabetic cataract | KG + DL |
| 22 | myasthenia, limb-girdle, autoimmune | KG + DL |
| 23 | irritable bowel syndrome | KG + DL |
| 24 | corneal neovascularization | KG + DL |
| 25 | nuclear senile cataract | KG + DL |
| 26 | cortical cataract | KG + DL |
| 27 | senile cataract | KG + DL |
| 28 | craniostenosis cataract | KG + DL |
| 29 | diabetes mellitus type 2 associated cataract | KG + DL |
| 30 | tetanic cataract | KG + DL |
| 31 | immature cataract | KG + DL |
| 32 | mature cataract | KG + DL |
| 33 | obsolete neurogenic bladder (disease) | KG + DL |
| 34 | obstructive lung disease | KG + DL |
| 35 | pulmonary edema | KG + DL |
| 36 | infective urethral stricture | KG + DL |
| 37 | post-bacterial disorder | KG + DL |
| 38 | Chagas cardiomyopathy | KG + DL |
| 39 | postinfectious vasculitis | KG + DL |
| 40 | large intestine disease | KG + DL |
| 41 | post-infectious syndrome | KG + DL |
| 42 | infection-related hemolytic uremic syndrome | KG + DL |
| 43 | small intestine disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.